thalidomide has been researched along with cysteine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hansen, JM; Harris, C; Harris, KK; Philbert, MA | 1 |
| Andreeff, M; Baran, N; Bhattacharya, S; Borthakur, G; Crews, CM; Davis, RE; Ishizawa, J; Kantarjian, H; Konopleva, M; Lorenzi, PL; McQueen, T; Mu, H; Piya, S; Qian, Y; Ruvolo, V; Wang, Z; You, MJ | 1 |
1 review(s) available for thalidomide and cysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for thalidomide and cysteine
| Article | Year |
|---|---|
Thalidomide modulates nuclear redox status and preferentially depletes glutathione in rabbit limb versus rat limb.
Topics: Animals; Cell Nucleus; Cells, Cultured; Chromatography, High Pressure Liquid; Cysteine; Female; Fluoresceins; Fluorescent Dyes; Glutathione; Hindlimb; Microscopy, Fluorescence; Muscle, Skeletal; Oxidation-Reduction; Oxidative Stress; Pregnancy; Rabbits; Rats; Rats, Sprague-Dawley; Species Specificity; Teratogens; Thalidomide | 2002 |
BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironment.
Topics: ADP-ribosyl Cyclase 1; Animals; Antigens, CD34; Azepines; Bone Marrow; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Cysteine; Gene Expression Profiling; Glutathione; HL-60 Cells; Humans; Hyaluronan Receptors; Leukemia, Myeloid, Acute; Leukocyte Common Antigens; Male; Membrane Glycoproteins; Mice; Neoplasm Transplantation; Neoplastic Stem Cells; Nuclear Proteins; Oxidative Stress; Phosphorylation; Receptors, CXCR4; Thalidomide; THP-1 Cells; Thy-1 Antigens; Transcription Factors; U937 Cells | 2019 |